Tag Archives: Chronic kidney disease

Novartis Reports Positive Results for Atrasentan in IgA Nephropathy Study

(IN BRIEF) Novartis has reported positive interim results from its Phase III ALIGN study involving atrasentan, an oral endothelin A receptor antagonist, for the treatment of IgA nephropathy (IgAN). The study demonstrated that atrasentan significantly reduced proteinuria (excess protein in … Read the full press release

GlaxoSmithKline: European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor used to treat patients with anaemia of chronic kidney disease

Submission for the treatment of anaemia of chronic kidney disease based on the ASCEND Phase III clinical trial programme, consisting of five trials that all met their co-primary efficacy and safety endpoints EMA file acceptance is the first major regulatory … Read the full press release

New data from AstraZeneca’s renal medicines will be presented at the 57th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress

(PRESS RELEASE) CAMBRIDGE, 5-Jun-2020 — /EuropaWire/ — British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca announced it will present new data across continuum of care from its broad renal portfolio during the 57th virtual congress of the European Renal Association – … Read the full press release

Hyperkalaemia: Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma

Hyperkalaemia - Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma

(PRESS RELEASE) CAMBRIDGE, 26-Mar-2020 — /EuropaWire/ — Science-led biopharmaceutical group AstraZeneca (LSE/STO/NYSE: AZN) has announced that its Lokelma (sodium zirconium cyclosilicate) is now approved in Japan. It is used for the treatment of patients with hyperkalaemia (elevated levels of potassium … Read the full press release

AstraZeneca will use BenevolentAI’s advanced AI to dive into its disease area expertise and massive datasets to gain insights into the complex disease biology

AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney disease and idiopathic pulmonary fibrosis (PRESS RELEASE) CAMBRIDGE / LONDON, 30-Apr-2019 — /EuropaWire/ — New partnership, announced today, by AstraZeneca … Read the full press release

University of Birmingham study links periodontitis to higher mortality rate in patients with chronic kidney disease

BIRMINGHAM, 19-Feb-2016 — /EuropaWire/ — New findings from the University of Birmingham show that patients with chronic kidney disease patients and periodontitis (severe gum disease) have a higher mortality rate than those with chronic kidney disease alone. The research, published in … Read the full press release

National Institute for Health Research (NIHR) Clinician Scientist Award for new University of Leicester research into preventing heart disease in dialysis patients

National award for new University of Leicester research into preventing heart disease in dialysis patients Leicester, UK, 10-2-2014 — /EuropaWire/ — A podcast recording of Dr James Burton explaining his new research project is available to embed and download at: http://soundcloud.com/university-of-leicester/james-burton … Read the full press release